NCT01224028View on ClinicalTrials.gov

A Study to Evaluate the Efficacy and Safety of Tacrolimus in Korean Nephropathy Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
IgA Nephropathy
Interventions
DRUG

Tacrolimus

oral

DRUG

Placebo

oral

Trial Locations (1)

Unknown

Seoul

Sponsors
All Listed Sponsors
collaborator

Astellas Pharma Korea, Inc.

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY